ribavirin has been researched along with Kidney Failure, Chronic in 76 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (1.32) | 18.2507 |
| 2000's | 27 (35.53) | 29.6817 |
| 2010's | 44 (57.89) | 24.3611 |
| 2020's | 4 (5.26) | 2.80 |
| Authors | Studies |
|---|---|
| Li, X; Lou, L | 1 |
| Akhan, S; Ergun, NC; Köse, Ş; Onlen, Y; Tatar, B; Turken, M; Yılmaz, Y | 1 |
| Jalota, A; Lerma, EV; Lindner, BK; Thomas, B | 1 |
| Abd-Elsalam, S; Abo-Amer, YE; Ahmed, R; Badawi, R; El-Abgeegy, M; Elguindy, AMA; Elkadeem, M; Elsergany, HF; Elshweikh, SA; Hawash, N; Mansour, L; Mohmed, AA; Soliman, MY; Soliman, S | 1 |
| Bair, MJ; Chen, CJ; Chen, CY; Chen, JJ; Cheng, JS; Cheng, PN; Chien, RN; Chiu, YC; Chu, CH; Chuang, WL; Dai, CY; Hsieh, MH; Huang, CF; Huang, JF; Huang, YH; Hung, CH; Kao, JH; Kuo, HT; Lai, HC; Lee, PL; Lin, CW; Lin, CY; Lin, HC; Liu, CH; Liu, CJ; Lo, CC; Lo, GH; Peng, CY; Su, WW; Tai, CM; Tsai, PC; Tsai, WL; Tseng, KC; Tung, SY; Wang, CC; Wang, JH; Yan, SL; Yang, CC; Yeh, ML; Yu, ML | 1 |
| Bhamidimarri, KR; Burke, G; Chen, L; Ciancio, G; Guerra, G; Kupin, W; Ladino, M; Martin, P; Mattiazzi, A; Pedraza, F; Roth, D | 1 |
| Lin, HC; Su, CW; Yang, YY | 1 |
| Maughan, A; Ogbuagu, O | 1 |
| Aoufi-Rabih, S; Fabrizi, F; García-Agudo, R; González-Corvillo, C; Salgueira-Lazo, M | 1 |
| Abdel-Aziz, EM; Abdel-Malek, MO; Hashim, AA; Hetta, HF; Mekky, MA; Morsy, KH; Osman, HA | 1 |
| Boyacıoğlu, AS; Çolak, T; Dağlı, Ü; Haberal, M; Hilmioğlu, F; Öcal, S; Özer Etik, D; Selçuk, H; Suna, N | 1 |
| Chen, J; Fang, Z; Li, M; Li, Y; Lin, Q | 1 |
| Chang, KC; Chen, TC; Chien, YS; Hu, TH; Hung, CH; Lee, CT; Lin, MT; Shen, CH; Tsai, MC; Tseng, PL; Yen, YH | 1 |
| Galle, PR; Knapstein, J; Zimmermann, T | 1 |
| Alsaran, K; Molhem, A; Sabry, A | 1 |
| Ho, HJ; Hsiao, NW; Hsu, YC; Huang, YT; Kao, YH; Lin, JT; Liu, YY; Wu, CY; Wu, MS | 1 |
| Bieber, B; Gillespie, B; Goodkin, DA; Jadoul, M; Robinson, BM | 1 |
| Chen, DS; Chen, PJ; Chen, SI; Chuang, WL; Dai, CY; Huang, CF; Huang, JF; Hung, PH; Kao, JH; Liang, CC; Lin, JW; Liu, CH; Liu, CJ; Su, TH; Tsai, HB; Tsai, MK; Yang, HC; Yang, SS; Yu, ML | 1 |
| Criado-Illana, MT; García-López, L; Hidalgo-Collazos, P; Marín-Ventura, L; Sánchez, R | 1 |
| Boots, JM; de Man, R; de Vries, MA; Samijn, JP | 1 |
| Abdelsalam, MS; Althaf, MM; Nadri, Q; Rashwan, M | 1 |
| Abraham, P; Alagammai, PL; Basu, G; Goel, A; Mahajan, R; Ramachandran, J; Sivakumar, J; Tamilarasi, V | 1 |
| Ho, HJ; Hsu, YC; Huang, YT; Lin, JT; Wang, HH; Wu, CY; Wu, MS | 1 |
| Ahn, SB; Choe, WH; Chung, JI; Jun, DW; Jung, KS; Kim, DY; Kim, JK; Kim, SG; Kim, W; Lee, SH; Park, SY; Seo, YS; Shim, JJ; Shin, HP | 1 |
| Frankova, S; Hejda, V; Jirsa, M; Merta, D; Neroldova, M; Senkerikova, R; Sperl, J; Spicak, J; Viklicky, O; Volfova, M | 1 |
| Chung, RT; Corey, KE; Friedman, LS; Hundemer, GL; Sise, ME; Ufere, N; Wisocky, J | 1 |
| Pol, S; Vallet-Pichard, A | 1 |
| Akhan, S; Aynioglu, A; Sargin Altunok, E; Sayan, M | 1 |
| Abunimeh, M; Bennett, M; Bernstein, DE; Cohen, DE; Cohen, E; Khatri, A; Lawitz, E; Mantry, PS; Pockros, PJ; Podsadecki, T; Reddy, KR; Shulman, NS; Sulkowski, MS; Wang, D | 1 |
| Diago, M; Peño, L; Plana, L; Urquijo, JJ | 1 |
| Aggarwal, R; Bhadauria, DS; Goel, A; Gupta, A; Kaul, A; Prasad, N; Rai, P; Sharma, RK | 1 |
| Burger, D; Gevers, TJ; Kooistra, MP; Richter, C; Schipper-Reintjes, E | 1 |
| Amundsen, BM; Chandraker, A; Chung, RT; Chute, D; Curry, MP; Elias, N; Gabardi, S; Hanifi, JM; Heher, EC; Lin, MV; Pavlakis, M; Riella, LV; Rutherford, AE; Sise, ME | 1 |
| Alric, L; Kamar, N; Rostaing, L | 1 |
| Cameron, A; Fenkel, JM; Frank, AM; Shah, AP; Singh, P | 1 |
| Kaya, S | 1 |
| Al-Saran, K; Sabry, A; Shaheen, N; Yehia, A | 1 |
| Duffin, RP; Ichim, TE; Joyce, JA; Levin, NW; Tullis, RH | 1 |
| Curciarello, J; Fernández, JL; Silva, M | 1 |
| Araya, V; Bingaman, A; Grewal, KS; Horton, J; Olson, MR; Ortiz, J; Stewart, S; Zaki, R | 1 |
| Alsaran, K; Sabry, A; Shaheen, N | 1 |
| Aqel, B; Balan, V; Byrne, T; Carey, E; Douglas, D; Heilman, RL; Mekeel, K; Rakela, J; Reddy, K; Vargas, HE; Werner, T | 1 |
| Abravanel, F; Alric, L; Basse, G; Cointault, O; Esposito, L; Garrouste, C; Izopet, J; Kamar, N; Lhomme, S; Nogier, MB; Peron, JM; Ribes, D; Rostaing, L | 1 |
| Ferguson, MC | 1 |
| Kao, JH; Liu, CH | 1 |
| Canva, V; Castel, H; Colin, M; Deltenre, P; Dharancy, S; Glowacki, F; Hazzan, M; Henrion, J; Lazrek, M; Louvet, A; Mathurin, P; Moreno, C; Noel, C; Ollivier, I; Provôt, F; Stanke, F; Tran, A | 1 |
| Elewa, U; Fervenza, FC; Poterucha, JJ; Sandri, AM | 1 |
| Glue, P; Gupta, SK; Kantesaria, B | 1 |
| Ahmed, U; Anas, A; Attia, M; Beejay, N; El-Azab, G; Giguere, A; Hassan, MH; Khalowf, M; Khan, A; Nasser, T; Nouh, M; Saleh, A | 1 |
| Campistol, JM; Esforzado, N | 1 |
| Dumortier, J; Gagnieu, MC; Guillaud, O; Janbon, B; Juillard, L; Leroy, V; Morelon, E | 1 |
| Alarcón, C; Arambarri, M; Echarri, R; Fernández Lucas, M; Merino, JL; Ortuño, J; Teruel, JL | 1 |
| Fabrizi, F; Martin, P; Poordad, FF | 2 |
| Charlton, M; Wiesner, R | 1 |
| Gonzalez, SA; Jacobson, IM | 1 |
| Akyuz, F; Besisik, F; Dincer, D; Karaca, C; Okten, A; Sever, MS | 1 |
| Bunnapradist, S; Fabrizi, F; Martin, P | 1 |
| Gane, E | 1 |
| Podlasin, RB | 1 |
| Bruchfeld, A; Carlsson, T; Lindahl, K; Reichard, O; Schvarcz, R | 2 |
| Koksal, I | 1 |
| Izopet, J; Kamar, N; Ribes, D; Rostaing, L | 1 |
| Abradelo, M; Castellano, G; Colina, F; Fernández, I; Fuertes, A; García, I; Lumbreras, C; Meneu, JC; Moreno, E; Muñoz, R; Solís-Herruzo, JA | 1 |
| Muir, AJ; Ramamurthy, M | 1 |
| Mátyus, J; Tornai, I | 1 |
| Amoruso, AC; Castellaneta, NM; Di Leo, A; Francavilla, A; Losito, F; Rendina, M; Schena, A; Schena, FP; Stallone, G | 1 |
| Amarapurkar, D; Bowden, S; Chow, WC; Chutaputti, A; Dore, G; Gane, E; Guan, R; Hamid, SS; Hardikar, W; Hui, CK; Jafri, W; Jia, JD; Lai, MY; Leung, N; McCaughan, GW; Omata, M; Piratvisuth, T; Sarin, S; Sollano, J; Tateishi, R; Wei, L | 1 |
| Karkar, A | 1 |
| Kalia, H; Lopez, PM; Martin, P | 1 |
| Ahmed, MS; Kapoor, N; Pandya, BK; Shawki, H; Wong, CF | 1 |
| Drenth, JP; Slavenburg, S | 1 |
| Fabrizi, F; Locatelli, F | 1 |
| Fontaine, H; Pol, S | 1 |
25 review(s) available for ribavirin and Kidney Failure, Chronic
| Article | Year |
|---|---|
Hepatitis C and Treatment in Patients with Chronic Kidney Disease.
Topics: Antiviral Agents; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Humans; Kidney Failure, Chronic; Kidney Transplantation; Patient Selection; Renal Dialysis; Renal Insufficiency, Chronic; Ribavirin | 2021 |
Impact of etiological treatment on prognosis.
Topics: Alcohol Abstinence; Antiviral Agents; Carcinoma, Hepatocellular; Combined Modality Therapy; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Hypertension, Portal; Interferon-alpha; Kidney Failure, Chronic; Liver Cirrhosis; Liver Diseases, Alcoholic; Liver Neoplasms; Liver Transplantation; Portal Pressure; Prognosis; Ribavirin | 2018 |
Pegylated interferon alpha 2a for the treatment of hepatitis C virus infection.
Topics: Antiviral Agents; Drug Interactions; Drug Therapy, Combination; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon-alpha; Kidney Failure, Chronic; Patient Selection; Pharmacogenetics; Polyethylene Glycols; Recombinant Proteins; Ribavirin | 2018 |
Sofosbuvir-based regimen is safe and effective for hepatitis C infected patients with stage 4-5 chronic kidney disease: a systematic review and meta-analysis.
Topics: Antiviral Agents; Drug Therapy, Combination; Genotype; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Humans; Kidney Failure, Chronic; Prospective Studies; Renal Insufficiency, Chronic; Ribavirin; Sofosbuvir; Sustained Virologic Response | 2019 |
Use of direct-acting agents for hepatitis C virus-positive kidney transplant candidates and kidney transplant recipients.
Topics: Amides; Antiviral Agents; Benzofurans; Carbamates; Cyclopropanes; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Imidazoles; Immunosuppressive Agents; Interferon-alpha; Kidney; Kidney Failure, Chronic; Kidney Transplantation; Polyethylene Glycols; Quinoxalines; Ribavirin; Sulfonamides; Transplant Recipients | 2016 |
[Treatment of chronic hepatitis C virus infection in hemodialysis patients].
Topics: Antiviral Agents; Contraindications; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Kidney Failure, Chronic; Polyethylene Glycols; Prevalence; Recombinant Proteins; Renal Dialysis; Ribavirin; Turkey | 2008 |
Modeling hepatitis C virus therapies combining drugs and lectin affinity plasmapheresis.
Topics: Antiviral Agents; Clinical Trials as Topic; Combined Modality Therapy; Drug Therapy, Combination; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Kidney Failure, Chronic; Mannose-Binding Lectins; Models, Biological; Plant Lectins; Plasmapheresis; Polyethylene Glycols; Recombinant Proteins; Renal Dialysis; Ribavirin; Sorption Detoxification; Treatment Outcome; Viral Load; Viremia | 2010 |
Current therapies for chronic hepatitis C.
Topics: Antiviral Agents; Drug Therapy, Combination; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Interferons; Kidney Failure, Chronic; Liver Cirrhosis; Male; Pregnancy; Pregnancy Complications, Infectious; Ribavirin; Treatment Outcome | 2011 |
Treatment of hepatitis C virus infection in patients with end-stage renal disease.
Topics: Antiviral Agents; Drug Therapy, Combination; Hepatitis C, Chronic; Humans; Interferons; Kidney Failure, Chronic; Kidney Transplantation; Renal Dialysis; Ribavirin; Treatment Outcome; Viral Load | 2011 |
Treatment of hepatitis C-mediated glomerular disease.
Topics: Adrenal Cortex Hormones; Antibodies, Monoclonal, Murine-Derived; Antiviral Agents; Drug Therapy, Combination; Hepacivirus; Hepatitis C, Chronic; Humans; Immunologic Factors; Interferon alpha-2; Interferon-alpha; Kidney Failure, Chronic; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Rituximab | 2011 |
Treatment of hepatitis C in dialysis patients.
Topics: Antiviral Agents; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Kidney Failure, Chronic; Liver Transplantation; Polyethylene Glycols; Recombinant Proteins; Renal Dialysis; Ribavirin | 2012 |
Natural history and management of hepatitis C infection after liver transplantation.
Topics: Disease Progression; Hepacivirus; Hepatitis C, Chronic; Humans; Immunoglobulins; Interferon alpha-2; Interferon-alpha; Kidney Failure, Chronic; Liver Transplantation; Polyethylene Glycols; Recombinant Proteins; Recurrence; Ribavirin | 2004 |
The role of hematopoietic growth factors in special populations with chronic hepatitis C: patients with HIV coinfection, end-stage renal disease, or liver transplantation.
Topics: Anemia; Antiviral Agents; Clinical Trials as Topic; Comorbidity; Drug Therapy, Combination; Erythropoietin; Forecasting; Granulocyte Colony-Stimulating Factor; Hepatitis C, Chronic; HIV Infections; Humans; Interferons; Kidney Failure, Chronic; Liver Transplantation; Neutropenia; Patient Compliance; Recombinant Proteins; Recurrence; Renal Dialysis; Ribavirin | 2004 |
Treatment of hepatitis C in potential kidney and heart transplant patients.
Topics: Antiviral Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Heart Failure; Heart Transplantation; Hepatitis C; Humans; Interferon Type I; Kidney Failure, Chronic; Kidney Transplantation; Recombinant Proteins; Renal Dialysis; Ribavirin | 2005 |
Treatment of chronic hepatitis C in patients with renal disease.
Topics: Algorithms; Antiviral Agents; Hepatitis C, Chronic; Humans; Interferons; Kidney Failure, Chronic; Kidney Transplantation; Renal Dialysis; Ribavirin | 2005 |
[Hepatitis C infections in dialyzed patients].
Topics: Antiviral Agents; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Kidney Failure, Chronic; Kidney Transplantation; Polyethylene Glycols; Recombinant Proteins; Renal Dialysis; Ribavirin; Risk Factors | 2005 |
Treatment of hepatitis C virus infection (HCV) after renal transplantation: implications for HCV-positive dialysis patients awaiting a kidney transplant.
Topics: Antiviral Agents; Hepacivirus; Hepatitis C; Humans; Interferon Type I; Kidney Failure, Chronic; Kidney Transplantation; Liver Function Tests; Prevalence; Recombinant Proteins; Renal Replacement Therapy; Ribavirin; Waiting Lists | 2006 |
Treatment of hepatitis C in special populations.
Topics: Adult; Antiviral Agents; Asian; Black or African American; Hepacivirus; Hepatitis C; Hispanic or Latino; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Kidney Failure, Chronic; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin | 2006 |
[Treatment of hepatitis C in patients on renal replacement therapy].
Topics: Antiviral Agents; Cross Infection; Disease Progression; Drug Therapy, Combination; Graft Rejection; Hepacivirus; Hepatitis C; Hepatitis C Antibodies; Humans; Immunosuppressive Agents; Interferon alpha-2; Interferon-alpha; Kidney Failure, Chronic; Kidney Transplantation; Liver; Liver Cirrhosis; Polyethylene Glycols; Recombinant Proteins; Renal Dialysis; Ribavirin | 2007 |
Hepatitis C in dialysis units: the Saudi experience.
Topics: Antiviral Agents; Education, Nursing, Continuing; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Infection Control; Interferon-alpha; Kidney Failure, Chronic; Prevalence; Renal Dialysis; Ribavirin; Saudi Arabia | 2007 |
Treatment of HCV in patients with renal failure.
Topics: Antiviral Agents; Drug Therapy, Combination; Hepatitis C, Chronic; Humans; Interferons; Kidney Failure, Chronic; Kidney Transplantation; Renal Dialysis; Ribavirin | 2007 |
Rapidly deteriorating renal function with membranoproliferative glomerulonephritis Type 1 associated with hepatitis C treated successfully with steroids and antiviral therapy: a case report and review of literature.
Topics: Adult; Anti-Inflammatory Agents; Antiviral Agents; Biopsy; Creatinine; Drug Therapy, Combination; Glomerulonephritis, Membranoproliferative; Glucocorticoids; Hepatitis C; Humans; Immunoglobulin M; Interferon alpha-2; Interferon-alpha; Kidney; Kidney Failure, Chronic; Male; Methylprednisolone; Nephrotic Syndrome; Polyethylene Glycols; Recombinant Proteins; Ribavirin | 2008 |
Combination of interferon alpha and ribavirin in the treatment of hepatitis C: implications for the clinical nephrologist.
Topics: Antiviral Agents; Drug Combinations; Hepatitis C; Humans; Interferon-alpha; Kidney Failure, Chronic; Nephrology; Ribavirin | 1999 |
[Prevention and treatment of viral hepatitis in renal insufficiency conditions].
Topics: Antiviral Agents; Biopsy; Comorbidity; Contraindications; Cryoglobulinemia; Female; Graft Rejection; Hepatitis B; Hepatitis B Vaccines; Hepatitis C; Humans; Immunosuppressive Agents; Interferon-alpha; Kidney Failure, Chronic; Kidney Transplantation; Lamivudine; Liver; Male; Renal Dialysis; Ribavirin; Severity of Illness Index | 2001 |
Hepatitis C infection and the patient with end-stage renal disease.
Topics: Cross Infection; Graft Survival; Hepatitis C; Humans; Interferons; Kidney Failure, Chronic; Kidney Transplantation; Renal Dialysis; Ribavirin; Survival Rate; Tissue Donors; Treatment Outcome | 2002 |
9 trial(s) available for ribavirin and Kidney Failure, Chronic
| Article | Year |
|---|---|
Efficacy and safety of pegylated interferon alfa-2b and ribavirin combination therapy versus pegylated interferon monotherapy in hemodialysis patients: a comparison of 2 sequentially treated cohorts.
Topics: Antiviral Agents; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Kidney Failure, Chronic; Male; Middle Aged; Polyethylene Glycols; Prospective Studies; Recombinant Proteins; Renal Dialysis; Ribavirin | 2013 |
Treatment of chronic hepatitis C with peginterferon alfa-2b, plus ribavirin in end stage renal disease patients treated by hemodialysis: single Saudi center experience.
Topics: Adult; Antiviral Agents; Erythropoietin; Female; Hemoglobins; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Kidney Failure, Chronic; Male; Middle Aged; Polyethylene Glycols; Prospective Studies; Recombinant Proteins; Renal Dialysis; Ribavirin; Saudi Arabia | 2013 |
Antiviral treatment for hepatitis C virus infection is associated with improved renal and cardiovascular outcomes in diabetic patients.
Topics: Acute Coronary Syndrome; Adult; Aged; Antiviral Agents; Cohort Studies; Comorbidity; Diabetes Mellitus; Drug Therapy, Combination; Female; Follow-Up Studies; Hepatitis C; Humans; Incidence; Interferon-alpha; Kidney Failure, Chronic; Male; Middle Aged; Multivariate Analysis; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Risk Factors; Stroke; Taiwan; Treatment Outcome | 2014 |
Pegylated interferon-α2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 1 receiving hemodialysis: a randomized trial.
Topics: Anemia; Antiviral Agents; Drug Therapy, Combination; Female; Genotype; Hemoglobins; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon-alpha; Kidney Failure, Chronic; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Renal Dialysis; Ribavirin; Viral Load | 2013 |
Efficacy of Direct-Acting Antiviral Combination for Patients With Hepatitis C Virus Genotype 1 Infection and Severe Renal Impairment or End-Stage Renal Disease.
Topics: 2-Naphthylamine; Aged; Anilides; Antiviral Agents; Carbamates; Cyclopropanes; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Genotype; Hepacivirus; Hepatitis C; Humans; Kidney Failure, Chronic; Lactams, Macrocyclic; Macrocyclic Compounds; Male; Middle Aged; Proline; Prospective Studies; Ribavirin; Ritonavir; Sulfonamides; Sustained Virologic Response; Uracil; Valine | 2016 |
Treatment of a common problem in hemodialysis patients: is the juice worth the squeeze?
Topics: Adult; Antiviral Agents; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Polyethylene Glycols; Prevalence; Recombinant Proteins; Renal Dialysis; Ribavirin; Saudi Arabia; Time Factors; Treatment Outcome | 2009 |
Pharmacokinetics, safety, and tolerability of ribavirin in hemodialysis-dependent patients.
Topics: Adult; Antiviral Agents; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis; Ribavirin | 2012 |
Pegylated interferon and ribavirin treatment for hepatitis C in haemodialysis patients.
Topics: Adult; Antiviral Agents; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Kidney Failure, Chronic; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Renal Dialysis; Retrospective Studies; Ribavirin; RNA, Viral | 2006 |
The treatment of chronic hepatitis C with peginterferon alfa-2a (40 kDa) plus ribavirin in haemodialysed patients awaiting renal transplant.
Topics: Adult; Antiviral Agents; Drug Therapy, Combination; Female; Follow-Up Studies; Hepacivirus; Hepatitis C, Chronic; Humans; Injections, Subcutaneous; Interferon alpha-2; Interferon-alpha; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Pilot Projects; Polyethylene Glycols; Preoperative Care; Recombinant Proteins; Renal Dialysis; Ribavirin; RNA, Viral; Treatment Outcome | 2007 |
42 other study(ies) available for ribavirin and Kidney Failure, Chronic
| Article | Year |
|---|---|
Comment on "Response to direct-acting antiviral agents in chronic hepatitis C patients with end-stage renal disease: a clinical experience".
Topics: Antiviral Agents; Hepatitis C, Chronic; Humans; Kidney Failure, Chronic; Ribavirin | 2021 |
Response to direct-acting antiviral agents in chronic hepatitis C patients with end-stage renal disease: a clinical experience.
Topics: 2-Naphthylamine; Adult; Aged; Anilides; Antiviral Agents; Carbamates; Cyclopropanes; Drug Therapy, Combination; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Kidney Failure, Chronic; Lactams, Macrocyclic; Macrocyclic Compounds; Male; Middle Aged; Proline; Ribavirin; Ritonavir; RNA, Viral; Statistics, Nonparametric; Sulfonamides; Sustained Virologic Response; Time Factors; Treatment Outcome; Uracil; Valine; Young Adult | 2019 |
Efficacy and safety of ombitasvir/paritaprevir/ritonavir/ribavirin in management of Egyptian chronic hepatitis C virus patients with chronic kidney disease: A real-life experience.
Topics: Adult; Aged; Anilides; Antiviral Agents; Carbamates; Cyclopropanes; Drug Therapy, Combination; Egypt; Female; Hepatitis C, Chronic; Humans; Kidney Failure, Chronic; Lactams, Macrocyclic; Macrocyclic Compounds; Male; Middle Aged; Proline; Prospective Studies; Ribavirin; Ritonavir; Sulfonamides; Sustained Virologic Response; Valine | 2020 |
Long-term risk of end-stage renal diseases with maintenance dialysis among chronic hepatitis C patients after antiviral therapy in Taiwan.
Topics: Antiviral Agents; Drug Therapy, Combination; Hepacivirus; Hepatitis C, Chronic; Humans; Kidney Failure, Chronic; Renal Dialysis; Ribavirin; Taiwan; Treatment Outcome | 2021 |
Transplantation of kidneys from hepatitis C-positive donors into hepatitis C virus-infected recipients followed by early initiation of direct acting antiviral therapy: a single-center retrospective study.
Topics: Adult; Aged; Antiviral Agents; Benzimidazoles; Carbamates; Donor Selection; Drug Therapy, Combination; Female; Fluorenes; Follow-Up Studies; Hepatitis C, Chronic; Humans; Imidazoles; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Postoperative Care; Pyrrolidines; Retrospective Studies; Ribavirin; Simeprevir; Sofosbuvir; Tissue Donors; Treatment Outcome; Valine | 2017 |
'Real-life' experience with direct-acting antiviral agents for hepatitis C virus in end-stage renal disease.
Topics: Aged; Antiviral Agents; Benzimidazoles; Carbamates; Cohort Studies; Drug Therapy, Combination; Female; Fluorenes; Hepacivirus; Hepatitis C, Chronic; Humans; Imidazoles; Kidney Failure, Chronic; Male; Middle Aged; Pyrrolidines; Renal Dialysis; Retrospective Studies; Ribavirin; Simeprevir; Sofosbuvir; Sustained Virologic Response; Treatment Outcome; Uridine Monophosphate; Valine | 2018 |
Efficacy of ombitasvir/paritaprevir/ritonavir/ribavirin in management of HCV genotype 4 and end-stage kidney disease.
Topics: Adult; Aged, 80 and over; Algorithms; Anilides; Antiviral Agents; Carbamates; Cyclopropanes; Drug Combinations; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Kidney Failure, Chronic; Lactams, Macrocyclic; Macrocyclic Compounds; Male; Middle Aged; Proline; Prospective Studies; Ribavirin; Ritonavir; Sulfonamides; Treatment Outcome; Valine | 2019 |
Successful Treatment With Direct-Acting Antiviral Agents of Hepatitis C in Patients With End-Stage Renal Disease and Kidney Transplant Recipients.
Topics: 2-Naphthylamine; Adult; Aged; Anilides; Antiviral Agents; Carbamates; Cyclopropanes; Drug Interactions; Drug Therapy, Combination; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Lactams, Macrocyclic; Macrocyclic Compounds; Male; Middle Aged; Proline; Prospective Studies; Retrospective Studies; Ribavirin; Risk Factors; Ritonavir; Sulfonamides; Sustained Virologic Response; Time Factors; Treatment Outcome; Uracil; Valine | 2019 |
Antiviral triple therapy with boceprevir in a chronic hepatitis C haemodialysis patient awaiting kidney re-transplantation.
Topics: Adult; Antiviral Agents; Drug Carriers; Drug Therapy, Combination; Hepacivirus; Hepatitis C, Chronic; Humans; Immunosuppressive Agents; Interferon-alpha; Kidney Failure, Chronic; Kidney Transplantation; Male; Methylprednisolone; Polyethylene Glycols; Proline; Renal Dialysis; Ribavirin; Treatment Outcome; Viral Load | 2014 |
Hepatitis C infection is very rarely treated among hemodialysis patients.
Topics: Adult; Aged; Antiviral Agents; Female; Hepatitis C, Chronic; Humans; Interferons; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Prevalence; Proportional Hazards Models; Renal Dialysis; Ribavirin; Time Factors; Treatment Outcome | 2013 |
Summaries for patients. Pegylated interferon with or without ribavirin for patients with hepatitis C receiving hemodialysis.
Topics: Anemia; Antiviral Agents; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon-alpha; Kidney Failure, Chronic; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Renal Dialysis; Ribavirin | 2013 |
[Treatment of infection due to hepatitis C virus in haemodialysis].
Topics: Aged; Antiviral Agents; Female; Hepatitis C, Chronic; Humans; Interferon-alpha; Kidney Failure, Chronic; Polyethylene Glycols; Recombinant Proteins; Renal Dialysis; Ribavirin | 2014 |
Hepatitis E-associated encephalopathy in a renal transplant recipient.
Topics: Aged; Biopsy, Needle; Chronic Disease; Disease Progression; Electromyography; Female; Follow-Up Studies; Graft Survival; Hepatic Encephalopathy; Hepatitis E; Humans; Immunocompromised Host; Immunohistochemistry; Kidney Failure, Chronic; Kidney Transplantation; Liver Function Tests; Magnetic Resonance Imaging; Ribavirin; Severity of Illness Index; Transplant Recipients; Transplantation Immunology; Treatment Outcome; Viral Load | 2014 |
Acute hepatitis C infection in a renal transplant recipient: primacy of the liver or kidney?
Topics: Adult; Antiviral Agents; Female; Graft Rejection; Hepatitis C, Chronic; Humans; Interferon-alpha; Kidney Failure, Chronic; Kidney Transplantation; Medical Tourism; Nephrectomy; Polyethylene Glycols; Recombinant Proteins; Renal Dialysis; Ribavirin | 2014 |
Efficacy and safety of hepatitis C antiviral therapy in moderate and severe chronic kidney disease.
Topics: Adult; Antiviral Agents; Female; Hepatitis C; Humans; Interferons; Kidney Failure, Chronic; Male; Middle Aged; Renal Insufficiency, Chronic; Ribavirin; Severity of Illness Index; Treatment Outcome; Young Adult | 2014 |
Association between antiviral treatment and extrahepatic outcomes in patients with hepatitis C virus infection.
Topics: Acute Coronary Syndrome; Adult; Antiviral Agents; Autoimmune Diseases; Drug Therapy, Combination; Female; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Kidney Failure, Chronic; Male; Middle Aged; Polyethylene Glycols; Proportional Hazards Models; Recombinant Proteins; Ribavirin; Stroke; Treatment Outcome | 2015 |
Efficacy and safety of pegylated interferon base treatment in patients with chronic hepatitis C on dialysis.
Topics: Adult; Anemia; Antiviral Agents; Drug Therapy, Combination; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Kidney Failure, Chronic; Male; Middle Aged; Neutropenia; Patient Dropouts; Polyethylene Glycols; Recombinant Proteins; Renal Dialysis; Republic of Korea; Retrospective Studies; Ribavirin; Treatment Outcome | 2015 |
Relevance of low viral load in haemodialysed patients with chronic hepatitis C virus infection.
Topics: Adolescent; Adult; Aged; Antiviral Agents; Chi-Square Distribution; Drug Therapy, Combination; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon-alpha; Interferons; Interleukins; Kidney Failure, Chronic; Logistic Models; Male; Middle Aged; Multivariate Analysis; Phenotype; Polyethylene Glycols; Recombinant Proteins; Renal Dialysis; Retrospective Studies; Ribavirin; Risk Factors; Treatment Outcome; Viral Load; Young Adult | 2015 |
Use of sofosbuvir-based direct-acting antiviral therapy for hepatitis C viral infection in patients with severe renal insufficiency.
Topics: Adult; Aged; Antiviral Agents; Drug Therapy, Combination; Female; Genotype; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Humans; Interferon-alpha; Kidney Failure, Chronic; Liver Cirrhosis; Male; Middle Aged; Polyethylene Glycols; Retrospective Studies; Ribavirin; RNA, Viral; Sofosbuvir; Treatment Outcome; Viral Load | 2015 |
[Management of hepatitis B virus and hepatitis C virus infection in chronic kidney failure].
Topics: Antiviral Agents; Biomarkers; Contraindications; Hepacivirus; Hepatitis B; Hepatitis B virus; Hepatitis C; Humans; Interferon-alpha; Kidney Failure, Chronic; Kidney Transplantation; Polyethylene Glycols; Recombinant Proteins; Renal Dialysis; Ribavirin | 2015 |
A case report: antiviral triple therapy with telaprevir in a haemodialysed HCV patient in Turkey.
Topics: Antiviral Agents; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferon-alpha; Kidney Failure, Chronic; Middle Aged; Oligopeptides; Polyethylene Glycols; Recombinant Proteins; Ribavirin | 2015 |
Difficult management of triple therapy for chronic hepatitis C in a patient on haemodialysis.
Topics: Anemia, Hemolytic; Antiviral Agents; Bacteremia; Blood Component Transfusion; Catheter-Related Infections; Drug Therapy, Combination; Glomerulonephritis; Graft Rejection; Hepatitis C, Chronic; Humans; Immunosuppression Therapy; Interferon-alpha; Kidney Failure, Chronic; Kidney Transplantation; Liver Cirrhosis; Male; Middle Aged; Oligopeptides; Polyethylene Glycols; Postoperative Complications; Recombinant Proteins; Renal Dialysis; Ribavirin; Staphylococcal Infections; Thrombocytopenia | 2017 |
Safety and effectiveness of response-guided therapy using pegylated interferon and ribavirin for chronic hepatitis C virus infection in patients on maintenance dialysis.
Topics: Adolescent; Adult; Antiviral Agents; Drug Monitoring; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Polyethylene Glycols; Predictive Value of Tests; Recombinant Proteins; Recurrence; Renal Dialysis; Retrospective Studies; Ribavirin; RNA, Viral; Time Factors; Treatment Outcome; Viral Load; Young Adult | 2017 |
Full-dose sofosbuvir and daclatasvir for chronic hepatitis C infection in haemodialysis patients.
Topics: Antiviral Agents; Carbamates; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Imidazoles; Kidney Failure, Chronic; Liver Cirrhosis; Male; Middle Aged; Pyrrolidines; Renal Dialysis; Ribavirin; RNA, Viral; Sofosbuvir; Sustained Virologic Response; Valine; Viral Load | 2016 |
Efficacy and Safety of Direct Acting Antivirals in Kidney Transplant Recipients with Chronic Hepatitis C Virus Infection.
Topics: Adult; Aged; Antiviral Agents; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Kidney Failure, Chronic; Kidney Transplantation; Liver Cirrhosis; Male; Middle Aged; Retrospective Studies; Ribavirin; Simeprevir; Sofosbuvir; Transplant Recipients; Treatment Outcome | 2016 |
Successful treatment of donor-derived hepatitis C viral infection in three transplant recipients from a donor at increased risk for bloodborne pathogens.
Topics: Acetaminophen; Adult; Allografts; Antiviral Agents; Benzimidazoles; Blood-Borne Pathogens; Chemical and Drug Induced Liver Injury; Disease Transmission, Infectious; Drug Therapy, Combination; Female; Fluorenes; Hepacivirus; Hepatitis C; Humans; Kidney Failure, Chronic; Kidney Transplantation; Liver Transplantation; Male; Middle Aged; Polymerase Chain Reaction; Ribavirin; RNA, Viral; Sofosbuvir; Transplant Recipients; Viral Load | 2017 |
[Treatment in chronic renal failure].
Topics: Antiviral Agents; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Kidney Failure, Chronic; Kidney Transplantation; Polyethylene Glycols; Recombinant Proteins; Renal Dialysis; Ribavirin | 2005 |
An international survey of the diagnosis, management, and treatment of hepatitis C in patients with end-stage renal disease.
Topics: Antiviral Agents; Biopsy; Evidence-Based Medicine; Guideline Adherence; Health Care Surveys; Hepatitis C; Humans; Informed Consent; Interferons; Kidney Failure, Chronic; Kidney Transplantation; Practice Guidelines as Topic; Practice Patterns, Physicians'; Predictive Value of Tests; Ribavirin; Surveys and Questionnaires; Tissue Donors; Treatment Outcome | 2009 |
Pegylated interferon alpha-2a for treatment of chronic HCV infection in hemodialysis patients: a single Saudi center experience.
Topics: Adolescent; Adult; Alanine Transaminase; Anemia; Antiviral Agents; Aspartate Aminotransferases; Drug Therapy, Combination; Female; Genotype; Hemoglobins; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon-alpha; Kidney Failure, Chronic; Leukocyte Count; Male; Middle Aged; Platelet Count; Polyethylene Glycols; Recombinant Proteins; Renal Dialysis; Ribavirin; RNA, Viral; Saudi Arabia | 2011 |
Treatment of hepatitis C in renal transplantation candidates: a single-center experience.
Topics: Adult; Antibodies, Monoclonal; Antilymphocyte Serum; Antiviral Agents; Basiliximab; Female; Hepatitis C; Humans; Immunosuppressive Agents; Interferon alpha-2; Interferon-alpha; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Polyethylene Glycols; Polymerase Chain Reaction; Recombinant Fusion Proteins; Recombinant Proteins; Ribavirin; RNA, Viral; Treatment Outcome; Waiting Lists | 2010 |
Ribavirin therapy inhibits viral replication on patients with chronic hepatitis e virus infection.
Topics: Aged; Antiviral Agents; Chronic Disease; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Hepatitis Antibodies; Hepatitis E; Hepatitis E virus; Humans; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Pilot Projects; Retrospective Studies; Ribavirin; RNA, Viral; Treatment Outcome; Virus Replication | 2010 |
Anti-viral therapy in haemodialysed HCV patients: efficacy, tolerance and treatment strategy.
Topics: Adult; Antiviral Agents; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Renal Dialysis; Ribavirin; Time Factors; Treatment Outcome; Viral Load | 2011 |
Treatment of hepatitis C virus infection in patients on maintenance hemodialysis: a single United Arab Emirates center experience.
Topics: Adult; Antiviral Agents; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Kidney Failure, Chronic; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Renal Dialysis; Retrospective Studies; Ribavirin; Treatment Outcome; United Arab Emirates | 2011 |
Anti-viral triple therapy with telaprevir in haemodialysed HCV patients: is it feasible?
Topics: Adult; Anemia; Antiviral Agents; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferons; Kidney Failure, Chronic; Male; Middle Aged; Oligopeptides; Renal Dialysis; Ribavirin; RNA, Viral; Treatment Outcome; Viral Load | 2013 |
[Therapy with interferon plus ribavirin in hemodialysis patient with PCR-positive viral hepatitis C].
Topics: Adult; Anemia; Antiviral Agents; Blood Transfusion; Drug Therapy, Combination; Hepacivirus; Hepatitis C; Humans; Interferon-alpha; Kidney Failure, Chronic; Male; Polymerase Chain Reaction; Renal Dialysis; Ribavirin; RNA, Viral; Vesico-Ureteral Reflux; Viremia | 2004 |
Hepatitis C infection associated with renal disease and chronic renal failure.
Topics: Graft Rejection; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Kidney Diseases; Kidney Failure, Chronic; Kidney Transplantation; Polyethylene Glycols; Recombinant Proteins; Ribavirin | 2004 |
Ribavirin treatment in patients with chronic hepatitis C infection who had renal transplantation.
Topics: Adult; Antiviral Agents; Female; Hepatitis C, Chronic; Humans; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Ribavirin; Treatment Failure | 2005 |
Pegylated interferon and ribavirin in haemodialysis patients.
Topics: Cohort Studies; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Kidney Failure, Chronic; Polymerase Chain Reaction; Recombinant Proteins; Renal Dialysis; Ribavirin; Risk Assessment; RNA, Viral; Treatment Outcome | 2006 |
Pegylated interferon for treatment in hemodialysis patients with chronic hepatitis C.
Topics: Antiviral Agents; Clinical Trials as Topic; Drug Therapy, Combination; Genotype; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Kidney Failure, Chronic; Polyethylene Glycols; Recombinant Proteins; Renal Dialysis; Ribavirin; Risk Factors | 2006 |
Clinical and histological efficacy of pegylated interferon and ribavirin therapy of recurrent hepatitis C after liver transplantation.
Topics: Adult; Antiviral Agents; Drug Therapy, Combination; Female; gamma-Glutamyltransferase; Hepacivirus; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Kidney Failure, Chronic; Liver Transplantation; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Recurrence; Ribavirin; RNA, Viral; Treatment Outcome | 2006 |
Asian Pacific Association for the Study of the Liver consensus statements on the diagnosis, management and treatment of hepatitis C virus infection.
Topics: Adult; Antiviral Agents; Asia; Australia; Child; Communicable Disease Control; Genotype; Hemophilia A; Hepacivirus; Hepatitis B; Hepatitis C; Hepatitis C Antibodies; HIV Infections; Humans; Immunoenzyme Techniques; Interferon-alpha; Kidney Failure, Chronic; Liver Transplantation; Molecular Diagnostic Techniques; Reagent Kits, Diagnostic; Ribavirin; RNA, Viral; Thalassemia; Treatment Outcome; Viral Load | 2007 |
Treatment of chronic hepatitis C in haemodialysis patients requires more ribavirin.
Topics: Adult; Antiviral Agents; Dose-Response Relationship, Drug; Drug Therapy, Combination; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Kidney Failure, Chronic; Male; Polyethylene Glycols; Recombinant Proteins; Renal Dialysis; Ribavirin; Treatment Outcome | 2008 |